Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > Kalytera Defaults on GVHD Program
View:
Post by MiSdyngNASTY on May 25, 2020 8:01am

Kalytera Defaults on GVHD Program

No revenue. Can't pay debts up to 100m now. Defaulting on GVHD program. Will lose it back to Talent. Begging for a new "acquisition". You all got played again. Same old scam shell company Kalytera. Kalytera acquired its GVHD program through the acquisition of Talent Biotechs Ltd. (Talent) in 2017. Kalyteras subsidiary, Kalytera Therapeutics Israel Ltd. (Kalytera Israel) owns the assets of the GVHD program, and is in default under a Promissory Note evidencing a USD $3 million debt that is owed by Kalytera Israel to the former shareholders of Talent
Comment by MiSdyngNASTY on May 25, 2020 8:27am
It's unbelievable that you guys keep falling for the same Kalytera tricks.
Comment by Whydoyoutroll1 on May 25, 2020 9:15am
You're such a loser lol. The program is going strong, no where near being defaulted. At this point I say everyone on this board treats him like a little kid acting up for attention; let's ignore the dummy 
Comment by MiSdyngNASTY on May 25, 2020 9:20am
Read it bud. Kalytera acquired its GVHD program through the acquisition of Talent Biotechs Ltd. (Talent) in 2017. Kalyteras subsidiary, Kalytera Therapeutics Israel Ltd. (Kalytera Israel) owns the assets of the GVHD program, and is in default under a Promissory Note evidencing a USD $3 million debt that is owed by Kalytera Israel to the former shareholders of Talent
Comment by MiSdyngNASTY on May 25, 2020 10:07am
Or this?
Comment by JamesNeven1983 on May 25, 2020 10:14am
Lol ok shorty .. whatever you say penny. Nice to see you creating an imaginary support base here. Lol stress kills, its a nice day outside go for a walk. Dont worry about us we are fine. If it was so horrible you would have been long gone but here we are. Focus on your own and not posters on this board with legit discussions vs your repeated doom and gloom which has never came or happened. You' ...more  
Comment by Chritters on May 25, 2020 10:27am
Couldnt have said it any better JamesNevan1983. Anything Covid-19 related right now is the MoneyTrain!!
Comment by MiSdyngNASTY on May 25, 2020 10:28am
If anyone was shorting they covered when this was at one penny. Don't be foolish. This company has been doing poorly for three years straight because they have zero revenue, a ton of debt, and a terrible CEO. Don't blame me.
Comment by JamesNeven1983 on May 25, 2020 10:46am
Blah blah blah penny .. lol ok ok doom and gloom etc etc .. spazzing all over your ish again. Nothing was abandoned .. we just went in mainstream .. but ofc you are right and everyone is wrong. Have gone to see the Dr. yet about your severe multiple personality disorders? Something has to give. But for now blah blah blah blah. Stop stressing youre not saving anyone. No one takes you seriously.
Comment by MiSdyngNASTY on May 25, 2020 11:13am
They admitted it in the press release. I'm not making anything up lol
Comment by MiSdyngNASTY on May 25, 2020 12:29pm
How is this a successful company?
Comment by MyKnight on May 25, 2020 12:35pm
Just wait and see before the end of the summer... We all know how and what you are... Good luck to all long....
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities